We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+35.4%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$268M
AUM Growth
+$45.6M
Cap. Flow
+$18.2M
Cap. Flow %
6.78%
Top 10 Hldgs %
33.7%
Holding
508
New
146
Increased
78
Reduced
73
Closed
186

Top Buys

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$9.09M
2
LITE icon
Lumentum
LITE
+$8.24M
3
GLW icon
Corning
GLW
+$6.49M
4
INTC icon
Intel
INTC
+$5.94M
5
ALAB icon
Astera Labs
ALAB
+$4.77M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$9.07M
2
MOH icon
Molina Healthcare
MOH
+$8.9M
3
ELV icon
Elevance Health
ELV
+$8.08M
4
BTSG icon
BrightSpring Health Services
BTSG
+$3.52M
5
TERN
Terns Pharmaceuticals
TERN
+$2.78M

Sector Composition

Rank Sector Weight
1 Technology 44.62%
2 Healthcare 29.67%
3 Financials 9.04%
4 Consumer Discretionary 3.92%
5 Energy 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JANX icon
276
CALL
Janux Therapeutics
JANX
$978M
$19K 0.01%
80
– –
OCGN icon
277
CALL
Ocugen
OCGN
$458M
$18.3K 0.01%
+758
New +$1.31K
ALLY icon
278
PUT
Ally Financial
ALLY
$13.6B
$17.4K 0.01%
+94
New +$3.87K
IBIT icon
279
PUT
iShares Bitcoin Trust
IBIT
$47.2B
$15.6K 0.01%
+122
New +$5.28K
VTGN icon
280
VistaGen Therapeutics
VTGN
$11.8M
$15.2K 0.01%
26,612
– –
CTMX icon
281
CALL
CytomX Therapeutics
CTMX
$730M
$14K 0.01%
+801
New +$4.07K
MRK icon
282
PUT
Merck
MRK
$334B
$12.5K ﹤0.01%
+253
New +$29.2K
DELL icon
283
CALL
Dell
DELL
$320B
$12.4K ﹤0.01%
+15
New +$2K
MRVL icon
284
CALL
Marvell Technology
MRVL
$199B
$12K ﹤0.01%
+22
New +$1.85K
ROIV icon
285
PUT
Roivant Sciences
ROIV
$26.2B
$11.1K ﹤0.01%
860
– –
DOCN icon
286
CALL
DigitalOcean
DOCN
$15.6B
$10K ﹤0.01%
+15
New +$946
GLXY
287
PUT
Galaxy Digital Inc
GLXY
$4.07B
$9.82K ﹤0.01%
+73
New +$1.74K
INO icon
288
CALL
Inovio Pharmaceuticals
INO
$93M
$8.55K ﹤0.01%
190
-77
-29% -$127
CUE icon
289
Cue Biopharma
CUE
$131M
$7.67K ﹤0.01%
+1,112
New +$10.4K
MRNA icon
290
PUT
Moderna
MRNA
$25.4B
$7.35K ﹤0.01%
+404
New +$18.8K
GLW icon
291
CALL
Corning
GLW
$137B
$6.74K ﹤0.01%
+7
New +$844
ENTX icon
292
Entera Bio
ENTX
$141M
$6.53K ﹤0.01%
+5,881
New +$8.25K
ALMS
293
PUT
Alumis Inc
ALMS
$3.11B
$6.07K ﹤0.01%
+79
New +$1.98K
UTHR icon
294
PUT
United Therapeutics
UTHR
$21.5B
$5.62K ﹤0.01%
+51
New +$25.4K
ATYR
295
PUT
aTyr Pharma
ATYR
$54.2M
$4.99K ﹤0.01%
27
– –
LQDA icon
296
PUT
Liquidia Corp
LQDA
$6.45B
$4.18K ﹤0.01%
+126
New +$4.67K
SMCI icon
297
PUT
Super Micro Computer
SMCI
$25.3B
$4.15K ﹤0.01%
+83
New +$2.49K
RNA
298
Atrium Therapeutics
RNA
$211M
$3.78K ﹤0.01%
+283
New +$3.98K
CRSP icon
299
CALL
CRISPR Therapeutics
CRSP
$5.22B
$2.72K ﹤0.01%
270
+12
+5% +$633
ARKK icon
300
PUT
ARK Innovation ETF
ARKK
$6.54B
$2.61K ﹤0.01%
+49
New +$3.63K
10 11
12
13 14

Similar funds

SG
Standard General New York $336M AUM 16.52% 1-Year Est. Return
MA
MSA Advisors Santa Monica, California $333M AUM 8.79% 1-Year Est. Return
LA
LFL Advisers Evanston, Illinois $332M AUM 20.17% 1-Year Est. Return
RWM
Rench Wealth Management Denton, Texas $332M AUM 25.74% 1-Year Est. Return
BCM
Brightline Capital Management Miami, Florida $338M AUM 197.95% 1-Year Est. Return
JCA
Juniper Capital Advisors Houston, Texas $332M AUM 102.57% 1-Year Est. Return
EAM
EdenTree Asset Management London, United Kingdom $332M AUM 16.64% 1-Year Est. Return
CAC
Core Alternative Capital Peachtree Corners, Georgia $339M AUM 18.22% 1-Year Est. Return

Persistent Asset Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Persistent Asset Partners held 508 positions worth $268M, up 20% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Persistent Asset Partners deployed $18.2M of net new capital in Q1 2026, opening 146 new positions and adding to 78 existing holdings. Its largest new stake was Tower Semiconductor: 67,608 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Terns Pharmaceuticals, an estimated $2.78M trimmed.

  • Persistent Asset Partners's largest Q1 2026 buy was Tower Semiconductor: 67,608 shares worth $11.9M.
  • Persistent Asset Partners added most to Lumentum in Q1 2026, an estimated $8.24M increase.
  • Persistent Asset Partners's biggest Q1 2026 reduction was Terns Pharmaceuticals, cutting an estimated $2.78M.
  • Persistent Asset Partners fully exited Centene in Q1 2026, selling an estimated $9.07M.
  • Persistent Asset Partners's ten largest holdings make up 34% of its $268M portfolio in Q1 2026.
  • Persistent Asset Partners opened 146 new positions and closed 186 in Q1 2026.
  • Persistent Asset Partners's portfolio value rose 20% quarter-over-quarter to $268M.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.